Patricia Kovacevic - Cryomass Technologies Corp Counsel

All Insiders . USA . 
Stock . Cryomass Technologies . Stakeholders . Insider . Patricia Kovacevic
CRYM Stock  USD 0.02  0.0003  1.89%   

Insider

Patricia Kovacevic is Corp Counsel of Cryomass Technologies
Age 52
Phone303 416 7208
Webhttps://cryomass.com

Cryomass Technologies Management Efficiency

The company has return on total asset (ROA) of (0.3296) % which means that it has lost $0.3296 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1644) %, meaning that it created substantial loss on money invested by shareholders. Cryomass Technologies' management efficiency ratios could be used to measure how well Cryomass Technologies manages its routine affairs as well as how well it operates its assets and liabilities.
Cryomass Technologies currently holds 177.08 K in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Cryomass Technologies has a current ratio of 2.03, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Cryomass Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, Cryomass Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cryomass Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cryomass to invest in growth at high rates of return. When we think about Cryomass Technologies' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Mba BEconAvicanna
N/A
Linda Romano1CM Inc
N/A
Carlos MueteAvicanna
N/A
Belen MDMERCK Kommanditgesellschaft auf
63
Dirk ToepferMERCK Kommanditgesellschaft auf
N/A
Harshil Chovatiya1CM Inc
N/A
Ivana MaricAvicanna
N/A
Barbara WeilandMERCK Kommanditgesellschaft auf
49
Roland AlvarezAvicanna
N/A
Tanvi Bhandari1CM Inc
N/A
Matthias HeinzelMERCK Kommanditgesellschaft auf
56
Kamyar Hosseini1CM Inc
N/A
Gerhard SchmitzMERCK Kommanditgesellschaft auf
60
Caitlin JohnstonAvicanna
N/A
Frantz DevedecAvicanna
N/A
Friederike RotschMERCK Kommanditgesellschaft auf
51
Peter GuenterMERCK Kommanditgesellschaft auf
61
Cryomass Technologies Inc. designs, sells, and commercializes cryo-mechanical system for the handling of harvested hemp, cannabis, and other high-value plants. Cryomass Technologies Inc. was incorporated in 2011 and is headquartered in Denver, Colorado. Cryomass Technologies operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. Cryomass Technologies [CRYM] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Return On Equity-1.16
Return On Asset-0.33

Cryomass Technologies Leadership Team

Elected by the shareholders, the Cryomass Technologies' board of directors comprises two types of representatives: Cryomass Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cryomass. The board's role is to monitor Cryomass Technologies' management team and ensure that shareholders' interests are well served. Cryomass Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cryomass Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
BA BA, Chief Officer
Caroline Lenardon, Consultant
Ryan Smith, Chief Meds
Christian Noel, CEO Director
Janice Matthews, Consultant
Patricia Kovacevic, Corp Counsel
Stephen Schroeder, Consultant

Cryomass Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Cryomass Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-1.16
Return On Asset-0.33
Current Valuation42.41 M
Shares Outstanding202.53 M
Shares Owned By Insiders25.92 %
Price To Book4.44 X
Gross Profit37.18 K
EBITDA(7.9 M)
Net Income(12.86 M)
Cash And Equivalents2.19 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Cryomass OTC Stock

Cryomass Technologies financial ratios help investors to determine whether Cryomass OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cryomass with respect to the benefits of owning Cryomass Technologies security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY